Enrichment of AP1 at hypomethylated CpG sites and protection from DNA methylation by the AP1 family member c-Jun has been described in colon cancer and in BCR-ABL-induced lymphoid leukemia (Berman et al., 2011; Kollmann et al., 2011). Here, JUND is linked to colonic neoplasm.